These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 12220553)

  • 1. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS).
    Beebe AM; Cua DJ; de Waal Malefyt R
    Cytokine Growth Factor Rev; 2002; 13(4-5):403-12. PubMed ID: 12220553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
    Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
    Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments.
    Kollias G; Kontoyiannis D
    Cytokine Growth Factor Rev; 2002; 13(4-5):315-21. PubMed ID: 12220546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.
    Saxena A; Khosraviani S; Noel S; Mohan D; Donner T; Hamad AR
    Cytokine; 2015 Jul; 74(1):27-34. PubMed ID: 25481648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 and the interleukin-10 receptor.
    Moore KW; de Waal Malefyt R; Coffman RL; O'Garra A
    Annu Rev Immunol; 2001; 19():683-765. PubMed ID: 11244051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis.
    Kim S; Liva SM; Dalal MA; Verity MA; Voskuhl RR
    Neurology; 1999 Apr; 52(6):1230-8. PubMed ID: 10214749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus.
    Cross JT; Benton HP
    Inflamm Res; 1999 May; 48(5):255-61. PubMed ID: 10391113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.
    Mardani F; Mahmoudi M; Esmaeili SA; Khorasani S; Tabasi N; Rastin M
    J Cell Physiol; 2018 Jan; 234(1):642-649. PubMed ID: 30078223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
    Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
    Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
    Alleva DG; Kaser SB; Beller DI
    J Immunol; 1998 Dec; 161(12):6878-84. PubMed ID: 9862720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research Progress on Regulatory B Cells in Systemic Lupus Erythematosus.
    Wang T; Mei Y; Li Z
    Biomed Res Int; 2019; 2019():7948687. PubMed ID: 31240224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKT cells and autoimmune diseases: unraveling the complexity.
    Miyake S; Yamamura T
    Curr Top Microbiol Immunol; 2007; 314():251-67. PubMed ID: 17593664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
    Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
    J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Role of Interleukin-10 in Murine NZB/W F1 Lupus.
    Amend A; Wickli N; Schäfer AL; Sprenger DTL; Manz RA; Voll RE; Chevalier N
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement.
    Baraczka K; Nékám K; Pozsonyi T; Jakab L; Szongoth M; Seszták M
    Neuroimmunomodulation; 2001; 9(1):49-54. PubMed ID: 11435752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking the VISTA pathway enhances disease progression in (NZB × NZW) F1 female mice.
    Sergent PA; Plummer SF; Pettus J; Mabaera R; DeLong JK; Pechenick DA; Burns CM; Noelle RJ; Ceeraz S
    Lupus; 2018 Feb; 27(2):210-216. PubMed ID: 28659048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
    Borel P; Benkhoucha M; Weber MS; Zamvil SS; Santiago-Raber ML; Lalive PH
    Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of NK cells in autoimmune disease.
    Baxter AG; Smyth MJ
    Autoimmunity; 2002 Feb; 35(1):1-14. PubMed ID: 11908701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis.
    Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY
    Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BAFF suppresses IL-15 expression in B cells.
    Ma N; Xing C; Xiao H; He Y; Han G; Chen G; Hou C; Marrero B; Wang Y; Zhang S; Shen B; Li Y; Wang R
    J Immunol; 2014 May; 192(9):4192-201. PubMed ID: 24670802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.